1. Home
  2. CVGW vs LXEO Comparison

CVGW vs LXEO Comparison

Compare CVGW & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Calavo Growers Inc.

CVGW

Calavo Growers Inc.

HOLD

Current Price

$24.09

Market Cap

423.1M

ML Signal

HOLD

Logo Lexeo Therapeutics Inc.

LXEO

Lexeo Therapeutics Inc.

HOLD

Current Price

$6.57

Market Cap

486.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CVGW
LXEO
Founded
1924
2017
Country
United States
United States
Employees
1969
75
Industry
Specialty Foods
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
423.1M
486.1M
IPO Year
2002
2023

Fundamental Metrics

Financial Performance
Metric
CVGW
LXEO
Price
$24.09
$6.57
Analyst Decision
Buy
Strong Buy
Analyst Count
2
10
Target Price
$33.50
$18.60
AVG Volume (30 Days)
180.5K
705.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
3.38%
N/A
EPS Growth
1950.00
75.08
EPS
0.04
N/A
Revenue
$648,434,000.00
$654,000.00
Revenue This Year
$3.49
N/A
Revenue Next Year
$11.23
N/A
P/E Ratio
$591.75
N/A
Revenue Growth
N/A
N/A
52 Week Low
$18.40
$1.45
52 Week High
$28.72
$10.99

Technical Indicators

Market Signals
Indicator
CVGW
LXEO
Relative Strength Index (RSI) 36.20 41.71
Support Level $22.39 $6.15
Resistance Level $27.14 $7.77
Average True Range (ATR) 0.69 0.50
MACD -0.36 0.02
Stochastic Oscillator 28.04 14.02

Price Performance

Historical Comparison
CVGW
LXEO

About CVGW Calavo Growers Inc.

Calavo Growers Inc is engaged in the sourcing, packing, and distribution of fresh avocados, tomatoes, and papayas, and the processing of guacamole and other avocado products. The company delivers products to retail grocers, club and mass-merchandise stores, foodservice operators, and wholesalers, sourcing avocados from California, Mexico, and other key growing regions. Its operations include sorting, packing, ripening, and shipping fresh produce, and processing and packaging fresh and frozen guacamole. The company operates through two segments: Fresh, including avocados, tomatoes, papayas, and other fresh produce products, and Prepared, including guacamole and avocado pulp, with the majority of revenue generated from the Fresh segment and geographically from the United States.

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.

Share on Social Networks: